Foghorn Therapeutics (FHTX) Other Non Operating Income (2019 - 2026)

Foghorn Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$44000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 103.17% year-over-year to -$44000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 59.88% YoY), while the FY2025 annual figure was $3.4 million, down 19.26% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$44000.0, down from $502000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $1.4 million in Q4 2024, with the low at -$44000.0 in Q1 2026.
• The 5-year median for Other Non Operating Income is $712000.0 (2023), against an average of $758294.1.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income surged 152.0% in 2022, then sank 103.17% in 2026.
• Foghorn Therapeutics' Other Non Operating Income stood at $624000.0 in 2022, then gained by 8.65% to $678000.0 in 2023, then jumped by 107.37% to $1.4 million in 2024, then sank by 64.3% to $502000.0 in 2025, then sank by 108.76% to -$44000.0 in 2026.
• Business Quant data shows FHTX's Other Non Operating Income at -$44000.0 in Q1 2026, $502000.0 in Q4 2025, and $620000.0 in Q3 2025.